Planning for the FuturePlanning for the Future
March 1, 2006
Originally Published MX March/April 2006
Johnson & Johnson (J&J; New Brunswick, NJ) has completed its acquisition of insulin-delivery company Animas Corp. (West Chester, PA) in a transaction valued at about $518 million. Animas will operate as a stand-alone entity within J&J's subsidiary LifeScan Inc. (Milpitas, CA), which manufactures blood glucose-monitoring systems.
You May Also Like